What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Giampiero Girolomoni mainly investigates Psoriasis, Immunology, Cytokine, Internal medicine and Cell biology.
Psoriasis is a subfield of Dermatology that Giampiero Girolomoni explores.
His studies in Dermatology integrate themes in fields like Tacrolimus, Epidemiology, Disease and Rheumatology.
His study in Cytokine is interdisciplinary in nature, drawing from both Inflammation and Keratinocyte.
His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Cross-sectional study.
His work carried out in the field of Cell biology brings together such families of science as CXCL2, Dendritic cell, C-C chemokine receptor type 6, Receptor and Cytotoxic T cell.
His most cited work include:
- IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α (343 citations)
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). (226 citations)
- Mechanisms of immune-mediated skin diseases: an overview. (214 citations)
What are the main themes of his work throughout his whole career to date?
Giampiero Girolomoni focuses on Dermatology, Psoriasis, Immunology, Internal medicine and Atopic dermatitis.
His biological study spans a wide range of topics, including MEDLINE, Randomized controlled trial, Pathology, Quality of life and Severity of illness.
As part of the same scientific family, Giampiero Girolomoni usually focuses on Psoriasis, concentrating on Infliximab and intersecting with Adalimumab.
As part of his studies on Immunology, he often connects relevant subjects like Keratinocyte.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Surgery.
Giampiero Girolomoni is interested in Dupilumab, which is a branch of Atopic dermatitis.
He most often published in these fields:
- Dermatology (34.34%)
- Psoriasis (30.94%)
- Immunology (19.06%)
What were the highlights of his more recent work (between 2018-2021)?
- Dermatology (34.34%)
- Psoriasis (30.94%)
- Atopic dermatitis (13.21%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Dermatology, Psoriasis, Atopic dermatitis, Internal medicine and MEDLINE.
Giampiero Girolomoni interconnects Differential diagnosis, Methotrexate and Disease in the investigation of issues within Dermatology.
His Psoriasis study results in a more complete grasp of Immunology.
Giampiero Girolomoni combines subjects such as Moderate to severe, Observational study and Randomized controlled trial with his study of Atopic dermatitis.
His study connects Gastroenterology and Internal medicine.
His MEDLINE research is multidisciplinary, incorporating perspectives in Granulomatous Dermatitis, Medical prescription and Severity of illness.
Between 2018 and 2021, his most popular works were:
- Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients (30 citations)
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment. (29 citations)
- The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis. (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His main research concerns Psoriasis, Dermatology, Atopic dermatitis, Internal medicine and Immunology.
His Psoriasis study incorporates themes from Adalimumab, Obesity, Infliximab and Genetic predisposition.
His Dermatology study integrates concerns from other disciplines, such as Moderate to severe, Randomized controlled trial, Disease and MEDLINE.
His study looks at the relationship between Disease and topics such as Diabetes mellitus, which overlap with Pathogenesis and Fatty liver.
As part of one scientific family, Giampiero Girolomoni deals mainly with the area of Atopic dermatitis, narrowing it down to issues related to the Quality of life, and often Depression.
Immunology is closely attributed to Microbiome in his research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
